| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/28/2004 | US6797718 Ether substituted imidazopyridines |
| 09/28/2004 | US6797716 Imidazonaphthyridines |
| 09/28/2004 | US6797499 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 09/28/2004 | US6797491 Human papilloma virus treatment |
| 09/28/2004 | US6797285 Leaves of Cajanus Cajan(L.) Millsp and extract, formulation and uses thereof |
| 09/28/2004 | US6797268 Pharmaceutical composition useful in the treatment of peptic ulcers |
| 09/28/2004 | US6797266 Probiotic composition containing Lactobacillus casei strain ATCC PTA-3945 |
| 09/28/2004 | US6797263 Compositions and methods for achieving immune suppression |
| 09/28/2004 | US6797259 Delivery of muscle relaxants through an inhalation route |
| 09/28/2004 | US6796975 Container for linezolid intravenous solution |
| 09/28/2004 | CA2292359C Novel azalides and methods of making same |
| 09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 09/28/2004 | CA2162557C Conserved motif of hepatitis c virus e2/ns1 region |
| 09/28/2004 | CA2109028C Stabilized sorbic acid or salt thereof |
| 09/23/2004 | WO2004081214A1 Papillosin antimicrobial peptide, a gene for coding said peptide, a vector, a transformed organism and a compound containing said organism |
| 09/23/2004 | WO2004081036A1 Peptidic antibiotic |
| 09/23/2004 | WO2004081024A2 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 09/23/2004 | WO2004080976A1 Phthalazinone derivatives |
| 09/23/2004 | WO2004080966A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 09/23/2004 | WO2004080485A1 Preventive/remedy for diseases in upper digestive tract |
| 09/23/2004 | WO2004080475A1 Composition against infection with rotavirus and process for producing the same |
| 09/23/2004 | WO2004080455A1 Antibacterial agent and anticancer agent |
| 09/23/2004 | WO2004080453A1 Antihepatitis c virus agent and anti-hiv agent |
| 09/23/2004 | WO2004080398A2 1-amino 1h-imidazoquinolines |
| 09/23/2004 | WO2004069134A3 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 09/23/2004 | WO2004052365A3 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 09/23/2004 | WO2004050120A3 Treatment of prion-induced diseases by administration fo anti-prion antibodies |
| 09/23/2004 | WO2004013300A3 Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections |
| 09/23/2004 | WO2004005472A3 Inhibitors of ftsz and uses thereof |
| 09/23/2004 | WO2003094836A3 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 09/23/2004 | WO2003047341A3 Anti-microbial systems and methods |
| 09/23/2004 | WO2003043518A3 Methods and products for oral care |
| 09/23/2004 | WO2003037312A3 Ribavirin syrup formulations |
| 09/23/2004 | WO2003011209A8 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 09/23/2004 | US20040186293 Oxazolidinones having a benzannulated 6- or 7-membered heterocycle |
| 09/23/2004 | US20040186288 3,5-Diamino-1,2,4-triazoles as kinase inhibitors |
| 09/23/2004 | US20040186287 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides |
| 09/23/2004 | US20040186273 Prion-binding ligands and methods of using same |
| 09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/23/2004 | US20040186174 Hydroxydiphenyl ether compounds |
| 09/23/2004 | US20040186157 inhibiting kinases; for treating or preventing neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186130 Delivery of muscle relaxants through an inhalation route |
| 09/23/2004 | US20040186127 E.g., 7-(5-(2-(cyclohexylmethylamino)ethyl)indol-2-yl), 2-methyl-3H-imidazo(4,5-b)pyridine; antiinflammatory agents; antiproliferative agents; autoimmune diseases; reperfusion injuries; osteoporosis; bone disorders; antimetastasis agents |
| 09/23/2004 | US20040186125 E.g , 3-cyclohexyl-2-furan-3-yl-1Hindole-5-carboxylic acid; hepatitis C viricides that target RNA dependent RNA polymerases (Ns5B) in mammals, an enzyme essential to viral replication; used in conjunction with an mmunomodulatory agent, such as beta -, delta - gamma -, and omega -interferon |
| 09/23/2004 | US20040186096 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 09/23/2004 | US20040186072 Use of esters of long-chain fatty acids for treatment of autoimmune diseases |
| 09/23/2004 | US20040186045 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185507 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 09/23/2004 | US20040185496 Anti-bacterial methods and materials |
| 09/23/2004 | US20040185489 Gene transcription assay method |
| 09/23/2004 | US20040185433 such as acyclovir/valaciclovir or penciclovir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention |
| 09/23/2004 | US20040185122 Selective COX-2 inhibition from edible plant extracts |
| 09/23/2004 | US20040185113 Sparingly water-soluble calcium-containing inorganic microparticles and a drug or biodrug encapsulated therein; made by adding a calcium compound to a solution of a carbonate, phosphate, oxalate or urate and the drug to form the calcium salt of the carbonate, phosphate, oxalate or urate |
| 09/23/2004 | US20040185105 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| 09/23/2004 | US20040185058 Immunogenic polypeptides physically linked; anticarcinogenic, antitumor, antiallergen, and viricidal agents; autoimmune diseases; systemic or mucosal vaccines; genetic engineering |
| 09/23/2004 | US20040185048 Modulation of IL-2- and IL-15-mediated T cell responses |
| 09/23/2004 | US20040185032 enhanced development of prebiotic gastrointestinal ecology in patients with co-morbid diseases which exhibit problems secondary to impaired gastrointestinal health |
| 09/23/2004 | US20040185008 Delivery of compounds for the treatment of parkinsons through an inhalation route |
| 09/23/2004 | US20040185007 heating layers containing drugs such as benztropine, pergolide, ropinirole, amantadine and deprenyl on solid supports, to produce vapors, then condensing to aerosols which can be delivered by breathing; drug delivery method and devices |
| 09/23/2004 | US20040185006 Delivery of stimulants through an inhalation route |
| 09/23/2004 | US20040185005 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 09/23/2004 | US20040185004 Delivery of erectile dysfunction drugs through an inhalation route |
| 09/23/2004 | US20040185002 condensation aerosol for delivery of a drug selected from chlordiazepoxide, betahistine, clonidine, testosterone, a conjugated estrogen, an estrogen ester, estradiol, an estradiol ester, ethinyl estradiol, an ethinyl estradiol ester and hyoscyamine |
| 09/23/2004 | US20040185001 Delivery of physiologically active compounds through an inhalation route |
| 09/23/2004 | US20040185000 Delivery of antihistamines through an inhalation route |
| 09/23/2004 | US20040184999 Delivery of anti-migraine compounds through an inhalation route |
| 09/23/2004 | US20040184998 Delivery of drug esters through an inhalation route |
| 09/23/2004 | US20040184997 volatilizing a coating of drug on a solid support, having the surface texture of a metal foil, to a temperature sufficient to produce a heated vapor of drug and condensing the heated vapor to form condensation aerosol particles |
| 09/23/2004 | US20040184996 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 09/23/2004 | CA2801100A1 Novel antibacterial agents |
| 09/23/2004 | CA2518748A1 Antimicrobial agents and anticancer agents |
| 09/23/2004 | CA2517655A1 1-amino 1h-imidazoquinolines |
| 09/22/2004 | EP1460074A1 Substituted amino alkyl compounds |
| 09/22/2004 | EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 09/22/2004 | EP1459766A1 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 09/22/2004 | EP1459747A2 Method of inhibiting biosynthesis of Elf5A |
| 09/22/2004 | EP1459745A2 Method of inhibiting biosynthesis of elf5a |
| 09/22/2004 | EP1459744A2 Method of inhibiting biosynthesis of elf5a |
| 09/22/2004 | EP1458884A1 Method of screening for potential anti-bacterial agents |
| 09/22/2004 | EP1458870A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS |
| 09/22/2004 | EP1458863A1 A system for stable expression of sirnas in mammalian cells |
| 09/22/2004 | EP1458857A1 Hxhv virus, nucleic material, peptide material and uses |
| 09/22/2004 | EP1458757A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 09/22/2004 | EP1458756A1 Chemokine mutants acting as chemokine antagonists |
| 09/22/2004 | EP1458753A1 Modified bacterial surface layer proteins |
| 09/22/2004 | EP1458752A2 Polypeptides of pseudomonas aeruginosa |
| 09/22/2004 | EP1458748A2 Apoptotically active peptides |
| 09/22/2004 | EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| 09/22/2004 | EP1458735A2 Anti-viral 7-deaza l-nucleosides |
| 09/22/2004 | EP1458728A1 Crystalline cefdinir potassium dihydrate |
| 09/22/2004 | EP1458725A1 A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent |
| 09/22/2004 | EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 09/22/2004 | EP1458719A1 Pyridoquinoxaline antivirals |
| 09/22/2004 | EP1458718A1 Quinolinones as prostaglandin receptor ligands |
| 09/22/2004 | EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 09/22/2004 | EP1458712A2 Novel compounds |
| 09/22/2004 | EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 09/22/2004 | EP1458688A1 Quinazolinone derivative |